Considering the surgical margins used in TORS, is it necessary to cover the entire tongue base with an elective dose in IMRT of cT1-3 HPV+ squamous cell carcinoma grossly involving one side of the base of tongue?
For instance, VMAT planning can sometimes deliver very low doses to the contralateral base of tongue. Do you worry about this? What is your approach?
Completely agree. A large number of poorly selecte...